Shorter incubation period is associated with severe disease progression in patients with COVID-19

The diagnosed COVID-19 cases revealed that the incubation periods (IP) varied a lot among patients. However, few studies had emphasized on the different clinical features and prognosis of patients with different IP. A total of 330 patients with laboratory-confirmed COVID-19 were enrolled and classif...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Changxiang Lai, Rentao Yu, Mingbo Wang, Wenjie Xian, Xin Zhao, Qiyuan Tang, Ruikun Chen, Xuan Zhou, Xuan Li, Zhiyu Li, Zhiwei Li, Guohong Deng, Fang Wang
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2020
Materias:
Acceso en línea:https://doaj.org/article/f8a6dad879d943c1b94e8044420806d6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f8a6dad879d943c1b94e8044420806d6
record_format dspace
spelling oai:doaj.org-article:f8a6dad879d943c1b94e8044420806d62021-11-17T14:21:59ZShorter incubation period is associated with severe disease progression in patients with COVID-192150-55942150-560810.1080/21505594.2020.1836894https://doaj.org/article/f8a6dad879d943c1b94e8044420806d62020-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21505594.2020.1836894https://doaj.org/toc/2150-5594https://doaj.org/toc/2150-5608The diagnosed COVID-19 cases revealed that the incubation periods (IP) varied a lot among patients. However, few studies had emphasized on the different clinical features and prognosis of patients with different IP. A total of 330 patients with laboratory-confirmed COVID-19 were enrolled and classified into immediate onset group(IP<3 days, I group, 57 cases) and late onset group(IP>10 days, L group, 75 cases) based on IP. The difference of clinical characteristics and prognosis of the two groups were compared. There were more patients with fever in I group than in L group(P = 0.003), and counts of all the total lymphocytes, total T lymphocytes, CD4 + and CD8 + T lymphocytes were significantly different between the two groups(all P < 0.01). Besides, patients in L group had more GGOs in CT scan than I group and there were more patients in I group receiving antibiotic treatment than in L group(P < 0.001). For disease aggravation, the median CT scores were comparable between the two groups, but individually, there were more patients with increased CT score during hospitalization in I group than in L group. The aggravation incidence of CT presentation was 21.1% in I group, significantly higher than L group(8.0%, P = 0.042). Multivariable COX models suggested that IP was the only independent factors for CT aggravation. Conclusively, patients with different IP were different in clinical symptoms, laboratory tests, and CT presentations. Shorter IP was associated with the aggravation of lung involvement in CT scan.Changxiang LaiRentao YuMingbo WangWenjie XianXin ZhaoQiyuan TangRuikun ChenXuan ZhouXuan LiZhiyu LiZhiwei LiGuohong DengFang WangTaylor & Francis Grouparticleincubation periodcovid-19sars-cov-2disease aggravationct scoresInfectious and parasitic diseasesRC109-216ENVirulence, Vol 11, Iss 1, Pp 1443-1452 (2020)
institution DOAJ
collection DOAJ
language EN
topic incubation period
covid-19
sars-cov-2
disease aggravation
ct scores
Infectious and parasitic diseases
RC109-216
spellingShingle incubation period
covid-19
sars-cov-2
disease aggravation
ct scores
Infectious and parasitic diseases
RC109-216
Changxiang Lai
Rentao Yu
Mingbo Wang
Wenjie Xian
Xin Zhao
Qiyuan Tang
Ruikun Chen
Xuan Zhou
Xuan Li
Zhiyu Li
Zhiwei Li
Guohong Deng
Fang Wang
Shorter incubation period is associated with severe disease progression in patients with COVID-19
description The diagnosed COVID-19 cases revealed that the incubation periods (IP) varied a lot among patients. However, few studies had emphasized on the different clinical features and prognosis of patients with different IP. A total of 330 patients with laboratory-confirmed COVID-19 were enrolled and classified into immediate onset group(IP<3 days, I group, 57 cases) and late onset group(IP>10 days, L group, 75 cases) based on IP. The difference of clinical characteristics and prognosis of the two groups were compared. There were more patients with fever in I group than in L group(P = 0.003), and counts of all the total lymphocytes, total T lymphocytes, CD4 + and CD8 + T lymphocytes were significantly different between the two groups(all P < 0.01). Besides, patients in L group had more GGOs in CT scan than I group and there were more patients in I group receiving antibiotic treatment than in L group(P < 0.001). For disease aggravation, the median CT scores were comparable between the two groups, but individually, there were more patients with increased CT score during hospitalization in I group than in L group. The aggravation incidence of CT presentation was 21.1% in I group, significantly higher than L group(8.0%, P = 0.042). Multivariable COX models suggested that IP was the only independent factors for CT aggravation. Conclusively, patients with different IP were different in clinical symptoms, laboratory tests, and CT presentations. Shorter IP was associated with the aggravation of lung involvement in CT scan.
format article
author Changxiang Lai
Rentao Yu
Mingbo Wang
Wenjie Xian
Xin Zhao
Qiyuan Tang
Ruikun Chen
Xuan Zhou
Xuan Li
Zhiyu Li
Zhiwei Li
Guohong Deng
Fang Wang
author_facet Changxiang Lai
Rentao Yu
Mingbo Wang
Wenjie Xian
Xin Zhao
Qiyuan Tang
Ruikun Chen
Xuan Zhou
Xuan Li
Zhiyu Li
Zhiwei Li
Guohong Deng
Fang Wang
author_sort Changxiang Lai
title Shorter incubation period is associated with severe disease progression in patients with COVID-19
title_short Shorter incubation period is associated with severe disease progression in patients with COVID-19
title_full Shorter incubation period is associated with severe disease progression in patients with COVID-19
title_fullStr Shorter incubation period is associated with severe disease progression in patients with COVID-19
title_full_unstemmed Shorter incubation period is associated with severe disease progression in patients with COVID-19
title_sort shorter incubation period is associated with severe disease progression in patients with covid-19
publisher Taylor & Francis Group
publishDate 2020
url https://doaj.org/article/f8a6dad879d943c1b94e8044420806d6
work_keys_str_mv AT changxianglai shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT rentaoyu shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT mingbowang shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT wenjiexian shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT xinzhao shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT qiyuantang shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT ruikunchen shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT xuanzhou shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT xuanli shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT zhiyuli shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT zhiweili shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT guohongdeng shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
AT fangwang shorterincubationperiodisassociatedwithseverediseaseprogressioninpatientswithcovid19
_version_ 1718425456344039424